Jeffery Wyzykowski

Patent Agent
Full contact info

Experience

Sixth Street Invests in Blueprint Medicines

July 7, 2022

Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street. 

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Browne
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Michael Tuscan
Partner, Washington DC
Jon Cousin
Associate, Washington DC
Tanya Heare-Rowlands
Special Counsel, London
Matthew Everhart
Patent Agent, Washington DC
Jeffery Wyzykowski
Patent Agent, Washington DC
Matthew Scheideman
Patent Agent, Washington DC
Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Zack Gong
Associate, Shanghai
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Elizabeth Anne Wright
Partner, Brussels
Aaron Pomeroy
Partner, Colorado
Michael Klein
Partner, New York
Paul Springer
Associate, New York
Megan Browdie
Partner, Washington DC
Howard Morse
Partner, Washington DC

Related Practices & Industries

Forbius Agrees to Sell to Bristol Myers Squibb

August 25, 2020

Cooley advised Forbius – a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases – on its agreement to sell to Bristol Myers Squibb. Barbara Borden, Marya Postner and Rowook Park led the Cooley team advising Forbius. 

Read more

Related contacts

Rowook Park
Partner, San Diego
Barbara Borden
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
David Dalton
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Lindsey O'Crump
Associate, Washington DC
Marya Postner
Partner, Palo Alto
Michael Tuscan
Partner, Washington DC
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Jane Adams
Partner, San Diego
Jeffery Wyzykowski
Patent Agent, Washington DC
Phil Mitchell
Partner, New York
Steve Cuss
Associate, London
Tanya Heare-Rowlands
Special Counsel, London

Related Practices & Industries

Cooley advises Zymergen on patent matters surrounding $400 million landmark agtech deal

February 22, 2016

Cooley advised Zymergen on patent prosecution and IP diligence matters surrounding its $400 million Series C funding which closed in December 2018 and was led by returning investor SoftBank Vision Fund. The deal is the largest round of funding for a US-based startup operating upstream in the food and agriculture supply chain. Cooley lawyers Erich Veitenheimer and Chris Holly headed the team advising Zymergen.

Zymergen is the world’s first molecular manufacturing technology company, developing molecules used in industries including agriculture, chemicals, materials, pharmaceuticals, electronics and more.

Cooley’s patent team advises Zymergen on all aspects of IP matters, including the company’s foundational high-throughput genomic engineering platform.

Related contacts

Chris Holly
Partner, Washington DC
Marcelo Pomeranz
Associate, San Diego
Catherine Cowley
Special Counsel, London
Jong-Jin (JJ) Han
Patent Agent, Washington DC
Michael McEvoy
Patent Agent, Washington DC
Jordan Phelan
Associate, Washington DC
Jeffery Wyzykowski
Patent Agent, Washington DC